These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23117715)

  • 1. [Dabigatran: beyond the RE-LY study].
    García Alegría J
    Rev Clin Esp; 2012 Mar; 212 Suppl 2():1-3. PubMed ID: 23117715
    [No Abstract]   [Full Text] [Related]  

  • 2. Insights from the dabigatran versus warfarin in patients with atrial fibrillation (RE-LY) trial.
    Khoo CW; Lip GY
    Expert Opin Pharmacother; 2010 Mar; 11(4):685-7. PubMed ID: 20105114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New oral anticoagulants in elderly patients.
    Barco S; Cheung YW; Eikelboom JW; Coppens M
    Best Pract Res Clin Haematol; 2013 Jun; 26(2):215-24. PubMed ID: 23953909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dabigatran etexilate (Pradaxa) for the treatment of atrial fibrillation.
    Belavic JM
    Nurse Pract; 2011 Sep; 36(9):6-7. PubMed ID: 21857210
    [No Abstract]   [Full Text] [Related]  

  • 5. [Dabigatran: transforming the management of oral anticoagulation].
    Suárez Ortega S
    Rev Clin Esp; 2012 Mar; 212 Suppl 2():15-22. PubMed ID: 23117717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dabigatran for stroke prevention in atrial fibrillation: the RE-LY trial.
    Paikin JS; Haroun MJ; Eikelboom JW
    Expert Rev Cardiovasc Ther; 2011 Mar; 9(3):279-86. PubMed ID: 21438804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Warfarin: is the end nigh? Please?
    Neilson RF
    J R Coll Physicians Edinb; 2010 Sep; 40(3):222-3. PubMed ID: 21127766
    [No Abstract]   [Full Text] [Related]  

  • 8. [Dabigatran versus Warfarin in patients with atrial fibrillation. Results of the RE-LY study].
    Liakishev AA
    Kardiologiia; 2009; 49(10):75-6. PubMed ID: 19845524
    [No Abstract]   [Full Text] [Related]  

  • 9. Should dabigatran replace warfarin for stroke prevention in AF?
    Drug Ther Bull; 2011 Oct; 49(10):114-7. PubMed ID: 21994438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dabigatran versus warfarin for patients with non-valvular atrial fibrillation: is the patient the winner?
    Grave S
    Aust Nurs J; 2011 Dec-2012 Jan; 19(6):30-3. PubMed ID: 22329103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dabigatran etexilate versus warfarin as the oral anticoagulant of choice? A review of clinical data.
    Ma TK; Yan BP; Lam YY
    Pharmacol Ther; 2011 Feb; 129(2):185-94. PubMed ID: 20920530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of dabigatran compared to warfarin in patients with paroxysmal, persistent, and permanent atrial fibrillation: results from the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) study.
    Flaker G; Ezekowitz M; Yusuf S; Wallentin L; Noack H; Brueckmann M; Reilly P; Hohnloser SH; Connolly S
    J Am Coll Cardiol; 2012 Feb; 59(9):854-5. PubMed ID: 22361407
    [No Abstract]   [Full Text] [Related]  

  • 13. Dabigatran challenges warfarin's superiority for stroke prevention in atrial fibrillation.
    Schwartz NE; Albers GW
    Stroke; 2010 Jun; 41(6):1307-9. PubMed ID: 20395603
    [No Abstract]   [Full Text] [Related]  

  • 14. New insights and results from the RE-LY trial.
    Cardiovasc J Afr; 2011; 22(5):284-6. PubMed ID: 21983958
    [No Abstract]   [Full Text] [Related]  

  • 15. Dabigatran etexilate, a new oral direct thrombin inhibitor, for stroke prevention in patients with atrial fibrillation.
    Siddiqui FM; Qureshi AI
    Expert Opin Pharmacother; 2010 Jun; 11(8):1403-11. PubMed ID: 20446854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. At last, a RE-LYable alternative to warfarin for atrial fibrillation.
    Hankey GJ
    Int J Stroke; 2009 Dec; 4(6):454-5. PubMed ID: 19930055
    [No Abstract]   [Full Text] [Related]  

  • 17. Does warfarin for stroke thromboprophylaxis protect against MI in atrial fibrillation patients?
    Lip GY; Lane DA
    Am J Med; 2010 Sep; 123(9):785-9. PubMed ID: 20655037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Scope of the latest RE-LY substudies: clinical implications].
    Ruiz-Giménez Arrieta N
    Rev Clin Esp; 2012 Mar; 212 Suppl 2():4-14. PubMed ID: 23117716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What are the emerging therapeutic alternatives to warfarin in stroke patients? How would the results of RE-LY benefit Pakistanis?
    Khan M; Raza E; Kamal AK
    J Pak Med Assoc; 2011 Jun; 61(6):612-3. PubMed ID: 22204226
    [No Abstract]   [Full Text] [Related]  

  • 20. Dabigatran in clinical practice.
    Nagarakanti R; Ellis CR
    Clin Ther; 2012 Oct; 34(10):2051-60. PubMed ID: 23031622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.